Department of Psychosocial Rehabilitation, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Medical Corporation Kouseikai, Kusatsu Hospital, 10-1 Kusatsu Umegadai, Nishi-ku, Hiroshima, 733-0864, Japan.
Psychiatr Q. 2023 Jun;94(2):265-280. doi: 10.1007/s11126-023-10031-0. Epub 2023 May 24.
Improving adherence to medication and quality of life is a challenge in treating bipolar disorder. Therefore, psychoeducation plays an important role. This study examined factors associated with long-term medication adherence in patients with bipolar disorder who participated in a short-term psychoeducation program. Additionally, the relationships between medication adherence and medication attitudes and quality of life (QOL) were assessed. Multiple regression analysis was conducted on 67 inpatients and outpatients using medication adherence (Brief Evaluation for Medication Influences and Beliefs [BEMIB] score) as the dependent variable and clinical and demographic variables before and after the program as explanatory variables, one year after completion of the program. Pearson's correlation coefficients were calculated for associations between patients' BEMIB score and medication attitudes (Drug Attitude Inventory-10 [DAI-10]) and QOL (World Health Organization QOL-26 [WHOQOL-26] score) before and after the program and one year after program completion. The results showed that the CSQ-8 J (Client Satisfaction Questionnaire-8 Japanese) and DAI-10 scores immediately after the program were significantly related to the BEMIB score one year after program completion. Both the BEMIB and DAI-10 showed significant positive correlations with several items of the WHOQOL-26, both after the program and one year after completion of the program. The results suggest that medication attitudes acquired through psychoeducation and program satisfaction impact long-term medication adherence. The study also indicates that medication attitudes and medication adherence after a psychoeducation program are associated with QOL. Thus, patients' subjective views after a psychoeducation program can play an important role in long-term medication adherence and QOL.
提高双相情感障碍患者的药物依从性和生活质量是治疗的挑战。因此,心理教育起着重要的作用。本研究考察了参加短期心理教育计划的双相情感障碍患者长期药物依从性的相关因素。此外,还评估了药物依从性与药物态度和生活质量(QOL)之间的关系。对 67 名住院和门诊患者使用药物依从性(简要评估药物影响和信念[BEMIB]评分)作为因变量,使用计划前后的临床和人口统计学变量作为解释变量,进行多元回归分析,在完成计划一年后进行。计算了患者 BEMIB 评分与药物态度(药物态度量表-10 [DAI-10])和 QOL(世界卫生组织生活质量量表-26 [WHOQOL-26]评分)在计划前后和计划完成一年后的相关性的皮尔逊相关系数。结果表明,计划后立即的 CSQ-8J(客户满意度问卷-8 日本)和 DAI-10 评分与计划完成一年后的 BEMIB 评分显著相关。BEMIB 和 DAI-10 与 WHOQOL-26 的几个项目在计划后和完成计划一年后均呈显著正相关。结果表明,通过心理教育获得的药物态度和对方案的满意度会影响长期的药物依从性。该研究还表明,心理教育计划后的药物态度和药物依从性与 QOL 相关。因此,心理教育计划后患者的主观观点可以在长期药物依从性和 QOL 中发挥重要作用。